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Cancer
WHO estimates for 2011: cancer, more 
deaths than all coronary heart disease 
or all stroke [1].
Example: Leukaemia, 3.2% of all 
deaths.
Highest in Northern America and 
Australia/New Zealand.
Africa, partly due to failure to diagnose 
[2].
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Inflammation, Tumors and 
Viruses
The link between chronic 
inflammation and cancer: pioneering 
work of Rudolf Virchow (1863).
Up to 20% of all human cancers.
Critical roles: proinflammatory 
cytokines, tumor-infiltrating myeloid 
and immune cells.
Initiation, promotion and progression 
to malignant metastasis [3].
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Inflammation, Tumors and 
Viruses
Even in cancers with no preceding 
inflammation: tumor stroma 





Anti-inflammatory: IL-10, TGF-β [3].
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Mechanism
6
Wang, K. and M. Karin (2015). "Tumor-Elicited 
Inflammation and Colorectal Cancer." Advances in Cancer 
Research.
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Key Mediators Linking Inflammation 
and Cancer
7
Kundu, J. K. and Y.-J. Surh (2008). "Inflammation: gearing the journey to 
cancer." Mutation Research/Reviews in Mutation Research 659(1): 15-30.
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Inflammation, Tumors and 
Viruses
Signaling pathways of protumorigenic 
effects of inflammation: feed-forward 
loop [4].
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NF-kB activation in immune 
cells
Cytokines Production
that activate NF-kB in cancer cells
Chemokines that attract more 
inflammatory cells
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Inflammation, Tumors and Viruses
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Grivennikov, S. I., et al. (2010). "Immunity, inflammation, and cancer." 
Cell 140(6): 883-899.
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TNF-α Link [5].
Balkwill, F. (2006). "TNF-α in promotion and progression of cancer." Cancer 
and Metastasis Reviews 25(3): 409-416.
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Inflammation, Tumors and 
Viruses
Infection, most important cause of 
cancer (2009) [7].
Oncogenic Viruses:
HTLV-1, HPV, HHV-8, EBV, HBV, HCV
Epigenetic changes.
Genomic DNA methylation [8-19].
Parvovirus B19
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Parvovirus B19
Human PVB19: small, non-enveloped, 
icosahedral, ssDNA, 5.6 kb, ITRs (3’ and 
5’).
Erythrovirus, the only member of 
Parvoviridae family causing human 
diseases.
Transmission: through the respiratory 
route.
Entering: EPCs (CD36+) through P antigen 
[22-23].
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Parvovirus B19
15
Broliden, K., et al. (2006). "Clinical aspects of 
parvovirus B19 infection." Journal of internal 
medicine 260(4): 285-304.
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Parvovirus B19
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Parvovirus B19
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Broliden, K., et al. (2006). "Clinical aspects of parvovirus B19 infection." 
Journal of internal medicine 260(4): 285-304.
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Parvovirus B19
18
Heegaard, E. D. and K. E. Brown (2002). "Human parvovirus B19." 
Clinical microbiology reviews 15(3): 485-505.












CNS (Encephalitis, Meningitis, Peripheral neuropathy) 
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Parvovirus B19
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Erythema Infectiosum (Fifth disease)
https://lookfordiagnosis.com/news.php?lang=1&term=Er
ythema+Infectiosum




Broliden, K., et al. (2006). "Clinical aspects of parvovirus B19 infection." 
Journal of internal medicine 260(4): 285-304.
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Parvovirus B19
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Young, N. S. and K. E. Brown (2004). "Parvovirus B19." New England Journal 
of Medicine 350(6): 586-597.
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Parvovirus B19 and Cell 
Death
Cell Death by B19V, apoptosis, 
necrosis, cell cycle arrest
Apoptosis: 2 major pathways, extrinsic
and intrinsic; both: activation of 
caspases.
Extrinsic: ligation of death ligands (i.e
Fas & TNF-α to death receptors 
(activation of caspases 8/10
Intrinsic (mitochondrion): Bcl-2 (Bax, 
Bak) – MOPS [29].
23
Shahin Amiri - MSc Student of Medical Biotechnology - Dec 2015








Previously: thought to be un-regulated 
cell death
Recently: a number of regulated non-
apoptotic cell death pathways [29].
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Parvovirus B19
Transcription of viral genome: single 
promoter (p6)
P6: regulation of synthesis of all nine 
viral transcripts
Non-spliced transcript: production of 
the nonstructural protein (NS1)
Eight transcripts: two capsid proteins 
(VP1 and VP2), 7.5 & 11-kDa proteins 
[23, 25]
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Parvovirus B19
NS1 (Multifunctional Protein):
 Influencing the activity of other viral 
and cellular promoters [28].
 Apoptosis (Connection btw TNF-α & 
NS1 pathways)
 IL6 activation (NF-κB)
 G0/G1 arrest etc [29].
VP1/2: inhibiting colony formation of 
BFU-E cells [30].
26
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Corcoran, A. and S. Doyle (2004). "Advances in the biology, 
diagnosis and host–pathogen interactions of parvovirus B19." 
Journal of medical microbiology 53(6): 459-475.





Trafficking in infected cells [26].
Apoptosis in EPC more than NS1 [27].
Result:
Virus Replication and Infectivity [26].
7.5 kDa Protein: Unknown
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Parvovirus B19
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Young, N. S. and K. E. Brown (2004). "Parvovirus B19." New England Journal 
of Medicine 350(6): 586-597.
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Parvovirus B19 and Leukemia
Patient, parvovirus, acute
lymphoblastic leukemia, remained 
parvovirus positive according (PCR 
testing) but no clinical symptoms for 
27 months off chemotherapy [20].
A higher proportion of human 
parvovirus B19-positive cases in 
leukaemic patients [21].
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